Brief: Kernel Launches Observational Study Using Flow2 Neuroimaging Technology To Identify Biomarkers Of Depression Treatment Response
29/08/2023 13:05
Aug 29 (Reuters) - Kernel Group Holdings Inc KRNL.O :
* KERNEL LAUNCHES OBSERVATIONAL STUDY USING FLOW2
NEUROIMAGING
TECHNOLOGY TO IDENTIFY BIOMARKERS OF DEPRESSION TREATMENT
RESPONSE
Source text for Eikon: ID:nBw5Y23gTa
Further company coverage: KRNL.O
Recent news on Kernel group
See all newsBrief: AIRO, Kernel Announce Effectiveness Of Registration Statement
Brief: Kernel Group Holdings, On May 2, Received Notice Of Delisting From Nasdaq
Brief: Kernel Group Holdings Extends Period To Consummate Initial Business Combination
Ukraine's Kernel starts new big oilseed refinery, media report
Brief: Kernel Group Holdings Extends Period To Consummate Initial Business Combination